🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,063 results for “BRIGHT MINDS BIOSCIENCES INC.” Clear

  1. 10-week smoking cessation group therapy combined with NicoDerm CQ

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 3 other completed

    1 trial

  2. Active referral

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 3 other active

    1 trial

  3. Acyclovir

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 3 small molecule completed

    1 trial

  4. Adderall-XR

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Use Disorder

    phase 3 small molecule completed

    1 trial

  5. Agitated Saline SoC

    BRIGHT MINDS BIOSCIENCES INC.

    Right-To-Left Shunt

    phase 3 small molecule active

    1 trial

  6. B007

    BRIGHT MINDS BIOSCIENCES INC.

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  7. B007

    BRIGHT MINDS BIOSCIENCES INC.

    Primary Membranous Nephropathy

    phase 3 small molecule active

    2 trials

  8. B013+Nab-Paclitaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Triple Negative Breast Cancer (TNBC)

    phase 3 small molecule completed

    1 trial

  9. Bedaquiline

    BRIGHT MINDS BIOSCIENCES INC.

    Multi-drug Resistant Tuberculosis

    phase 3 small molecule active

    1 trial

  10. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    HCV Negative Status

    phase 3 other completed

    1 trial

  11. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 3 other completed

    3 trials

  12. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Abuse

    phase 3 other completed

    1 trial

  13. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Behavior Therapy

    phase 3 other completed

    1 trial

  14. Behavioral Drug and HIV Risk Reduction Counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Opiate Dependence

    phase 3 other completed

    1 trial

  15. Bias retraining

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Use Disorder

    phase 3 other completed

    1 trial

  16. Booster Sessions

    BRIGHT MINDS BIOSCIENCES INC.

    Skill Development of Staff

    phase 3 other completed

    1 trial

  17. Brief Strategic Family Therapy (BSFT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  18. Brief advice

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 3 other completed

    1 trial

  19. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 3 other completed

    1 trial

  20. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 3 small molecule completed

    2 trials

  21. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 3 small molecule active

    1 trial

  22. Buprenorphine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 3 small molecule completed

    5 trials

  23. Buprenorphine + Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 3 small molecule completed

    1 trial

  24. Buprenorphine +OTP

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Addiction

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources